The leading news at lunchtime. Ros Childs brings you the day's top stories and the latest news as it unfolds, with reporters ...

Investment in Research & Development (R&D) for the quarter amounted to ₹480 crore, representing 9.2% of the company's total revenue.

Zydus Lifesciences' formulations business revenues increased by 30% year-on-year to Rs 2,417 crore. The business accounted ...